Skip to content

Long-term Prognosis of Emergency Aneurysmal Subarachnoid Hemorrhage

Long-term Prognosis of Emergency Aneurysmal Subarachnoid Hemorrhage: an MDT- Based Multicenter Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04785976
Acronym
LongTEAM
Enrollment
5000
Registered
2021-03-08
Start date
2012-04-01
Completion date
2032-04-01
Last updated
2023-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aneurysmal Subarachnoid Hemorrhage

Brief summary

Rupture of intracranial aneurysms can lead to extensive subarachnoid hemorrhage (SAH), a potentially fatal neurological emergency with mortality rates ranging from 8 to 67%. At present, surgical clipping (SC) and endovascular coiling (EC) are two main treatments for aneurysmal subarachnoid hemorrhage (aSAH), in recent years, the improvements in surgical equipment and techniques have already greatly improved the postoperative safety of patients. However, considering individual differences between patients, some still at risk due to possible complications during hospitalization or after discharge from the hospital, it will no doubt generate a large healthcare burden. This prospective, observational clinical trial (LongTEAM) is to improve the diagnosis and treatment effect and efficiency in this field, reducing mortality, medical costs, and medical burden, while opening up new avenues for interdisciplinary clinical practice and scientific research exploration.

Interventions

PROCEDURESurgical clipping and endovascular coiling

Surgical clipping: Apply aneurysm clip to clip the ruptured aneurysm. Endovascular coiling:Also called endovascular embolization, to block blood flow into an aneurysm.Preventing blood flow into an aneurysm helps to keep it from rupturing.

Sponsors

Peking University International Hospital
CollaboratorOTHER
Beijing Tiantan Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* All patients admitted to the emergency department of the investigator with aneurysmal subarachnoid hemorrhage are included in their prospective registry.

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Unfavorable neurological outcome (mRS>2)10 days after the procedureNumber of patients experiencing a unfavorable neurological outcome at discharge, defined as a modified Rankin Scale (mRS) score of \>2.

Secondary

MeasureTime frameDescription
Cognitive deficits10 days after the procedureNumber of patients experiencing a unfavorable neurological outcome at discharge,defined as changes in thinking, emotion, will and behavior.
Major adverse cardiac or cerebrovascular events10 days after the procedureNumber of patients experiencing an event including all-cause death, non-fatal cerebrovascular event, non-fatal any myocardial infarction and revascularization at discharge.

Countries

China

Contacts

Primary ContactRunting Li, MD
1011168227@qq.com+8615753166690
Backup ContactXiaolin Chen, MD
xiaolinchen488@hotmail.com+8613810624845

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026